BioLife Solutions
BLFS
192 hedge funds and large institutions have $1.23B invested in BioLife Solutions in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 68 increasing their positions, 63 reducing their positions, and 28 closing their positions.
4,957% more call options, than puts
Call options by funds: $354K | Put options by funds: $7K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
14% more capital invested
Capital invested by funds: $1.07B → $1.23B (+$154M)
8% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 63
0% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 28
1% less funds holding
Funds holding: 194 → 192 (-2)
4.21% less ownership
Funds ownership: 104.96% → 100.74% (-4.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$24M |
| 2 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
+$4.56M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.03M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.03M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$23.7M |
| 2 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$14.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6.68M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$5.96M |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$5.41M |
BLFS Hedge Fund Activity: Q3 2025 in Review
192 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2025, worth a combined $1.23B — up 14% from $1.07B a quarter earlier.
Fund positioning in BLFS was balanced in Q3 2025: 28 funds opened new positions, 28 closed out, 68 added to existing stakes and 63 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $24M. The largest seller was Casdin Capital, cutting an estimated $23.7M.
- 192 institutional investors held BioLife Solutions (BLFS) as of Q3 2025, down from 194 in Q2 2025.
- Funds reported $1.23B of BioLife Solutions stock for Q3 2025, up 14% quarter-over-quarter.
- 28 funds opened new BioLife Solutions positions in Q3 2025 and 28 closed out, a net change of 0 holders.
- The largest BioLife Solutions buyer in Q3 2025 was Fidelity Investments, an estimated $24M added.
- The largest BioLife Solutions seller in Q3 2025 was Casdin Capital, an estimated $23.7M sold.
Based on aggregated 13F filings for Q3 2025.